265 related articles for article (PubMed ID: 27803964)
21. The effects of glucocorticoid therapy.
Baxter JD
Hosp Pract (Off Ed); 1992 Sep; 27(9):111-4, 115-8, 123 passim. PubMed ID: 1522153
[TBL] [Abstract][Full Text] [Related]
22. Comparative assessment of hypothalamic-pituitary-adrenal axis suppression secondary to intrabursal injection of different glucocorticoids: a pilot study.
Guaraldi F; Gori D; Calderoni P; Castiello E; Pratelli L; Leporati M; Arvat E; Battaglia M
J Endocrinol Invest; 2019 Sep; 42(9):1117-1124. PubMed ID: 30877658
[TBL] [Abstract][Full Text] [Related]
23. HPA failure and glucocorticoid therapy.
Christy NP
Hosp Pract (Off Ed); 1984 Jul; 19(7):77-9, 83-4, 87-9, concl. PubMed ID: 6330137
[No Abstract] [Full Text] [Related]
24. [Glucocorticoid treatments and adrenal function].
Guignat L; de Bucy C; Bertherat J
Rev Prat; 2008 May; 58(9):966-70. PubMed ID: 18672662
[TBL] [Abstract][Full Text] [Related]
25. [Hypothalamo-pituitary-adrenocortical function during and after steroid therapy: recent data and critical review].
Goichot B; Wicky C; Grunenberger F; Schlienger JL
Ann Endocrinol (Paris); 2000 Nov; 61(5):452-8. PubMed ID: 11084396
[TBL] [Abstract][Full Text] [Related]
26. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test.
Lević Z; Micić D; Nikolić J; Stojisavljević N; Sokić D; Janković S; Kendereski A; Mavra M
J Endocrinol Invest; 1996 Jan; 19(1):30-4. PubMed ID: 8851689
[TBL] [Abstract][Full Text] [Related]
27. Relationship Between Epidural Steroid Dose and Suppression of Hypothalamus-Pituitary-Adrenal Axis.
Sim SE; Hong HJ; Roh K; Seo J; Moon HS
Pain Physician; 2020 Aug; 23(4S):S283-S294. PubMed ID: 32942788
[TBL] [Abstract][Full Text] [Related]
28. Novel insights into adrenal insufficiency in childhood.
Levy-Shraga Y; Pinhas-Hamiel O
Minerva Pediatr; 2014 Dec; 66(6):517-32. PubMed ID: 25058175
[TBL] [Abstract][Full Text] [Related]
29. Maternal use of prednisolone is unlikely to be associated with neonatal adrenal suppression-a single-center study of 16 cases.
de Vetten L; van Stuijvenberg M; Kema IP; Bocca G
Eur J Pediatr; 2017 Aug; 176(8):1131-1136. PubMed ID: 28695270
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-induced adrenal insufficiency.
Krasner AS
JAMA; 1999 Aug; 282(7):671-6. PubMed ID: 10517721
[No Abstract] [Full Text] [Related]
31. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications.
Wolthers OD; Honour JW
J Asthma; 1999 Sep; 36(6):477-86. PubMed ID: 10498042
[TBL] [Abstract][Full Text] [Related]
32. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
[TBL] [Abstract][Full Text] [Related]
33. [Do we still have glucocorticoid-induced adrenal insufficiency?].
Goichot B; Vinzio S; Luca F; Schlienger JL
Presse Med; 2007; 36(7-8):1065-71. PubMed ID: 17603919
[TBL] [Abstract][Full Text] [Related]
34. [Problems of corticosteroid-induced adrenal insufficiency in surgery].
Grabner W
Fortschr Med; 1977 Aug; 95(30):1866-8. PubMed ID: 198346
[TBL] [Abstract][Full Text] [Related]
35. Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study.
Einarsdottir MJ; Kristjansdottir HL; Bergthorsdottir R; Johannsson G; Trimpou P; Lewerin C; Ragnarsson O
Acta Haematol; 2024; 147(3):360-365. PubMed ID: 37757784
[TBL] [Abstract][Full Text] [Related]
36. Assessment of systemic corticosteroid activity.
Dluhy RG
Respir Med; 1997 Nov; 91 Suppl A():32-3. PubMed ID: 9474366
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management.
Karangizi AHK; Al-Shaghana M; Logan S; Criseno S; Webster R; Boelaert K; Hewins P; Harper L
BMC Nephrol; 2019 May; 20(1):154. PubMed ID: 31060510
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
[TBL] [Abstract][Full Text] [Related]
39. Safety analysis of long-term budesonide nasal irrigations in patients with chronic rhinosinusitis post endoscopic sinus surgery.
Soudry E; Wang J; Vaezeafshar R; Katznelson L; Hwang PH
Int Forum Allergy Rhinol; 2016 Jun; 6(6):568-72. PubMed ID: 26879335
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic doses of glucocorticoids: implications for oral medicine.
Baid SK; Nieman LK
Oral Dis; 2006 Sep; 12(5):436-42. PubMed ID: 16910913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]